Update on the epidemiology of obesity and type 2 diabetes mellitus in France.

被引:0
|
作者
Charles, MA [1 ]
机构
[1] INSERM, U258, F-94807 Villejuif, France
来源
DIABETES & METABOLISM | 2000年 / 26卷
关键词
epidemiology; diabetes; obesity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The INSEE national surveys in 1980 and 1991, and the OBEPI study in 1997, allowed to study the prevalence of overweight and obesity in France, as well as its increase during these past years. The number of adult obese individuals remained stable between 1980 and 1991. The 1997 estimation suggests a moderate increase. By contrast, the number of obese children has increased between 1980 and 1991, whatever the level of study of the mother. Several diseases are strongly linked with obesity, such as hype ruricemia, hypertension, coronary heart disease, diabetes mellitus. Thus the declared prevalence of diabetes is 2 % when BMI ranges from 18.5 to 25 kg/m(2), and reaches 20 % at a BMI > 34 kg/m(2) with age ranging 40-70 years old. The presence of obesity during childhood is also correlated with an increased mortality, with an enhanced prevalence of coronary heart disease, hyperuricemia, colon cancer in men, and joint disease in women during adulthood. An increase in the prevalence of diabetes is expected in the near future: demography, as children born after the war will reach age of 55-75, the lowering of glycemic threshold for the diagnosis of diabetes, increased prevalence of obesity a re the ma in explanations. Our health care system will need to evolve in order to deal with this increased number of patients, and measures have been recently set for that purpose.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [31] Obesity and Type 2 Diabetes in Children: Epidemiology and Treatment
    Pulgaron, Elizabeth R.
    Delamater, Alan M.
    CURRENT DIABETES REPORTS, 2014, 14 (08)
  • [32] SURFACTANT PROTEIN D LEVELS WITH OBESITY AND TYPE 2 DIABETES MELLITUS
    Alkwai, Hend
    Aboelnaga, Shimaa Mohammad
    Hussain, Rania Abdeen
    Khatoon, Fahmida
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2020, 18 (01): : 39 - 42
  • [33] Fibrogenesis in Fatty Liver Associated with Obesity and Diabetes Mellitus Type 2
    Kaz Jaskiewicz
    Robert Rzepko
    Zbigniew Sledzinski
    Digestive Diseases and Sciences, 2008, 53 : 785 - 788
  • [34] Anti-obesity drugs in the treatment of type 2 diabetes mellitus
    Quevedo, J.
    Tur, J.
    Serra, G.
    Burguera, B.
    AVANCES EN DIABETOLOGIA, 2010, 26 (03): : 161 - 166
  • [35] Obesity and gender differences in the risk of type 2 diabetes mellitus in Uganda
    Lasky, D
    Becerra, E
    Boto, W
    Otim, M
    Ntambi, J
    NUTRITION, 2002, 18 (05) : 417 - 421
  • [36] Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2
    Jaskiewicz, Kaz
    Rzepko, Robert
    Sledzinski, Zbigniew
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (03) : 785 - 788
  • [37] The links between sleep duration, obesity and type 2 diabetes mellitus
    Antza, Christina
    Kostopoulos, Georgios
    Mostafa, Samiul
    Nirantharakumar, Krishnarajah
    Tahrani, Abd
    JOURNAL OF ENDOCRINOLOGY, 2022, 252 (02) : 125 - 141
  • [38] Liraglutide for Type 2 diabetes and obesity: a 2015 update
    Iepsen, Eva Winning
    Torekov, Signe Sorensen
    Holst, Jens Juul
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (07) : 753 - 767
  • [39] Treat Obesity to Treat Type 2 Diabetes Mellitus
    Sulu, Cem
    Yumuk, Volkan Demirhan
    DIABETES THERAPY, 2024, 15 (03) : 611 - 622
  • [40] Management of Obesity in Patients with Type 2 Diabetes Mellitus
    Gagliardi, Lucia
    Witterti, Gary
    CURRENT DIABETES REVIEWS, 2007, 3 (02) : 95 - 101